AA
WST icon

Advisory Alpha’s West Pharmaceutical WST Stock Holding History

Advisory Alpha’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$633K Buy
1,763
+235
+15% +$71.8K 0.02% 317
2026
Q1 		$383K Buy
1,528
+398
+35% +$99K 0.01% 386
2025
Q4 		$311K Buy
1,130
+99
+10% +$27.1K 0.01% 410
2025
Q3 		$282K Buy
+1,031
New +$251K 0.01% 431

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Advisory Alpha's WST Position: Q2 2026 in Review

Advisory Alpha increased its West Pharmaceutical (WST) stake by 15% in Q2 2026, buying an estimated $71.8K and bringing the position to 1,763 shares worth $633K. The position accounts for 0.02% of the portfolio, ranked #317.

Advisory Alpha first reported a position in WST in Q3 2025 and has held it in 4 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Advisory Alpha held 1,763 shares of West Pharmaceutical worth $633K as of Q2 2026.
  • Advisory Alpha bought 235 West Pharmaceutical shares in Q2 2026, an estimated $71.8K.
  • West Pharmaceutical made up 0.02% of Advisory Alpha's portfolio in Q2 2026, its #317 holding.
  • Advisory Alpha first reported a position in West Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Advisory Alpha's 13F filing for Q2 2026, filed 11 Aug 2026.